Navigation Links
Scientists obtain anticancer medicines from the elecampe, a wild plant growing in the Mediterranean
Date:4/17/2008

This release is available in Spanish.

A group of scientists from the Department of Organic Chemistry and the Biotechnology Institute of the University of Granada have found out that the plant Dittirichia viscose, known as elecampe, can be used to obtain inhibitors of neurogenic vasodilatation, a significant progress in migraine and cancer treatments.

The study, supervised by professors Mara del Mar Herrador and Alejandro Fernndez Barrero, has been carried out by Julieta Vernica Cataln, assistant professor of the National University of Tucuman (Argentina) and researcher of the University of Granada, and it has been financed by the Unin Europea through the Programa Alban and the Ministerio de Ciencia y Tecnologa. Julieta Vernica used the elecampe plant, abundant in the Mediterranean area, to obtain a method for taking out and purifying a natural product known as ilicic acid.

A promising angiogenesis inhibitor

This acid has been used to develop an effective method of chemical synthesis and of industrial interest towards the pharmacologically active &-eudesmol (against migraine) and -eudesmol which inhibits in vivo selectively, the proliferation of endothelial cells, being a promising antiangiogenic.

Likewise, these researchers have made another important discovery: they have used the germacrona compound, obtained from the Baccharis latifolia, a plant growing in the Bolivian Andes, in a new chemical synthesis of the antitumoral -element. This natural product serves to inhibit selectively the vascular endothelial brain cells and it has been used as an agent to prevent cancer in brain tumours and met
'/>"/>

Contact: Alejandro Fernndez Barrero
afbarre@ugr.es
34-958-243-318
Universidad de Granada
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
2. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
3. Stem cells and cancer: Scientists investigate a fine balancing act
4. Scientists Block Prostate Cancer Cells Spread
5. Scientists solve mystery of polyketide drug formation
6. Scientists Uncover How HIV Hides Inside Cells
7. Scientists: New technique identifies molecular biomarkers for disease
8. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
9. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
10. Dental scientists convene in Dallas
11. Eminent scientists to lecture in Dallas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Spinal Elements, ... corporate headquarters in Carlsbad to 3115 Melrose Drive, ... from the company’s continued and projected growth and ... 8,500 square feet to over 40,000 square feet. ... Spinal Elements, indicated, “Our investment in these state-of-the-art ...
(Date:5/22/2013)... Lawrenceville, NJ and Los Angeles, CA (PRWEB) May 22, ... chairman of the board, The J. M. Smucker Company, ... GS1 Lifetime Achievement Awards yesterday at the GS1 General ... Los Angeles, California. Mr. Smucker and Mr. Wegman were ... adoption of GS1 Standards - the most broadly used ...
(Date:5/22/2013)... News) -- Children who are physically, sexually or emotionally ... later in life, a new review suggests. British ... likely to be obese as adults. They concluded that ... factor for obesity. "We found that being maltreated ... in adult life," study author Dr. Andrea Danese, a ...
(Date:5/22/2013)... cancer. However, when existing drugs boost p53, only a few tumors ... the journal Cell Reports shows how: tumors that live ... protein p21 than the protein PUMA; tumors that die have more ... shows a handful of genes that control this ratio. , "The ... Tumors turn it off and then they can avoid controls that ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal conjugate ... previous version used prior to 2010, the 7-valent pneumococcal ... published today in Vaccine . , The U.S. ... in 2010 after a series of trials. These trials ... of pneumococcal types than the previously used PCV7, did ...
Breaking Medicine News(10 mins):Health News:Spinal Elements®, Inc. Relocates Corporate Headquarters in Carlsbad 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Abused Children at Risk for Obesity as Adults: Study 2Health News:Study details genes that control whether tumors adapt or die when faced with p53 activating drugs 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
... low cost cutting-edge technologies that can be used to maximize ... had strokes, head injuries and other causes of aphasia re-engage ... Join an award winning speech-language pathologist who ... with aphasia. , , Research has shown that technology ...
... of broken bones , THURSDAY, June 11 (HealthDay News) -- ... person at greater risk for broken bones, a new study ... Mayo Clinic researchers revealed that the person fractured a bone ... breaks occurred in the bones of the hands and feet, ...
... ... new media age. , ... MA (Vocus) June 11, 2009 -- From cyberbullying and violent video games to social networking ... children. To help parents navigate this new and changing landscape, the Center on Media ...
... BOSTON, June 11 GlobalEquityReport.com is ... Investors who are interested in stocks on the move and in ... http://www.GlobalEquityReport.com , , Today,s ... Generex Biotechnology, Corp. (Nasdaq: GNBT ), Cell Therapeutics, Inc. ...
... realistic computer game will soon be used to help ... The Virtual Dental Implant Training Simulation Program is ... treatment protocols. It was designed by Medical College of ... Ltd., a developer of game-based technology for training, experimentation ...
... The Nintendo Wii may help treat symptoms of Parkinson,s ... says. Parkinson,s disease is a degenerative disease ... popular computer game console, which simulates various sports and ... but he found additional benefits as well. "The ...
Cached Medicine News:Health News:Innovative Interventions for Aphasia - Free Live and Recorded Webinar 2Health News:Might Weight-Loss Surgery Lead to Fractures? 2Health News:Center on Media and Child Health Launches "Ask the Mediatrician" 2Health News:Center on Media and Child Health Launches "Ask the Mediatrician" 3Health News:GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN 2Health News:Simulation helps students learn dental implant procedures 2Health News:Simulation helps students learn dental implant procedures 3Health News:Wii-hab may enhance Parkinson's treatment 2
(Date:5/22/2013)... 2013  Grifols, ein globales Unternehmen der ... , Spanien, präsentierte die Ergebnisse einer ... von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des ... ein Niveau anhebt, das innerhalb des für ... ist eine lebensbedrohliche, genetische Erkrankung, bei der ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces ... Pharmaceutical Guidebook Series (4) 2013 Edition Material and ... Imported Drug Registration: A Guidebook of Registration Application ... " to its online database. The ... medicines are always regarded by occidental as mysterious ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5
... June 28, 2011 The Mirixa Corporation and ... are pleased to announce that MirixaPro(SM), a Web-based ... patient care service delivery, will be deployed in ... agreement enabling CACDS to use a scalable, localized ...
... 2011 ,   The ... range of,new clinical data. The "Late-Breaking Clinical Trials" were ... SHPT study,(Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet,With ... June the,principal investigator of this study, Prof. Markus Ketteler,(Coburg, ...
Cached Medicine Technology:Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 2Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 3Update on IMPACT Study Results 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: